RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer.

IF 9.6 1区 生物学 Q1 CELL BIOLOGY Cell Death & Disease Pub Date : 2025-02-25 DOI:10.1038/s41419-025-07455-w
Lanqing Huo, Xiaodan Huang, Ying Wang, Yi Ouyang, Xueping Zheng, Yingyi Ouyang, Xinping Cao, Kai Chen, Denghui Wei, Yuanzhong Wu, Ruhua Zhang, Yujie Lin, Tiebang Kang, Ying Gao
{"title":"RAB33A promotes metastasis via RhoC accumulation through non-canonical autophagy in cervical cancer.","authors":"Lanqing Huo, Xiaodan Huang, Ying Wang, Yi Ouyang, Xueping Zheng, Yingyi Ouyang, Xinping Cao, Kai Chen, Denghui Wei, Yuanzhong Wu, Ruhua Zhang, Yujie Lin, Tiebang Kang, Ying Gao","doi":"10.1038/s41419-025-07455-w","DOIUrl":null,"url":null,"abstract":"<p><p>Cervical cancer metastasis is characterized by the systemic spread of tumor cells. However, the underlying mechanism remains incompletely understood. Herein, we demonstrate that RAB33A promoted metastasis by enhancing RhoC accumulation and that higher RAB33A expression predicted poorer prognosis in patients with cervical cancer. Mechanistically, RhoC typically degraded via canonical autophagy due to the binding of two LIR motifs (LC3 interaction region) in RhoC to LC3; however, RAB33A induced non-canonical autophagy, resulting in RhoC stabilization, which facilitated pseudopodia formation and consequently cervical cancer metastasis. The fusion of RAB33A-induced autophagosomes with lysosomes was impaired, as RAB33A inactivated RAB7 by interacting with TBC1D2A, a GTPase-activating protein that targets RAB7. Our findings reveal a pivotal role of the RAB33A-RhoC axis in cervical cancer metastasis, indicating that RhoC inhibitors may be beneficial for treating cervical cancer patients with high levels of RAB33A.</p>","PeriodicalId":9734,"journal":{"name":"Cell Death & Disease","volume":"16 1","pages":"130"},"PeriodicalIF":9.6000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11861591/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell Death & Disease","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1038/s41419-025-07455-w","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Cervical cancer metastasis is characterized by the systemic spread of tumor cells. However, the underlying mechanism remains incompletely understood. Herein, we demonstrate that RAB33A promoted metastasis by enhancing RhoC accumulation and that higher RAB33A expression predicted poorer prognosis in patients with cervical cancer. Mechanistically, RhoC typically degraded via canonical autophagy due to the binding of two LIR motifs (LC3 interaction region) in RhoC to LC3; however, RAB33A induced non-canonical autophagy, resulting in RhoC stabilization, which facilitated pseudopodia formation and consequently cervical cancer metastasis. The fusion of RAB33A-induced autophagosomes with lysosomes was impaired, as RAB33A inactivated RAB7 by interacting with TBC1D2A, a GTPase-activating protein that targets RAB7. Our findings reveal a pivotal role of the RAB33A-RhoC axis in cervical cancer metastasis, indicating that RhoC inhibitors may be beneficial for treating cervical cancer patients with high levels of RAB33A.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
RAB33A在宫颈癌中通过非典型自噬通过RhoC积累促进转移。
宫颈癌转移的特点是肿瘤细胞的全身扩散。然而,潜在的机制仍然不完全清楚。本研究证明RAB33A通过增强RhoC积累促进转移,RAB33A表达升高预示宫颈癌患者预后较差。在机制上,由于RhoC中的两个LIR基序(LC3相互作用区)与LC3结合,RhoC通常通过典型自噬降解;然而,RAB33A诱导非典型自噬,导致RhoC稳定,促进假足形成,从而促进宫颈癌转移。RAB33A诱导的自噬体与溶酶体的融合受损,因为RAB33A通过与靶向RAB7的gtpase激活蛋白TBC1D2A相互作用使RAB7失活。我们的研究结果揭示了RAB33A-RhoC轴在宫颈癌转移中的关键作用,表明RhoC抑制剂可能有益于治疗高水平RAB33A的宫颈癌患者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cell Death & Disease
Cell Death & Disease CELL BIOLOGY-
CiteScore
15.10
自引率
2.20%
发文量
935
审稿时长
2 months
期刊介绍: Brought to readers by the editorial team of Cell Death & Differentiation, Cell Death & Disease is an online peer-reviewed journal specializing in translational cell death research. It covers a wide range of topics in experimental and internal medicine, including cancer, immunity, neuroscience, and now cancer metabolism. Cell Death & Disease seeks to encompass the breadth of translational implications of cell death, and topics of particular concentration will include, but are not limited to, the following: Experimental medicine Cancer Immunity Internal medicine Neuroscience Cancer metabolism
期刊最新文献
NUP93 facilitates the nuclear import of SOX2 to activate G3BP1 transcription and impairs gemcitabine response in pancreatic cancer. ZNRF1 deficiency disrupts Fas ligand trafficking and immune balance. LMO7-mediated POLR2A degradation promotes cellular senescence through the MDM4/p53/p21 axis. APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction. Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1